This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: The Rockefeller University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Nathaniel Kastan: Innovator in Cellular Proliferation and Hearing Loss Treatment
Introduction: Nathaniel Kastan is an accomplished inventor based in New York, NY (US). He is currently affiliated with The Rockefeller University, where he focuses on innovative research in cellular proliferation and hearing loss treatment. Although he has not yet been granted any patents, his work is significant in the field of biomedical research.
Latest Patent Applications: Nathaniel Kastan has submitted several notable patent applications. One of his latest applications is titled "Pyrrolopyridine-3- and 4-Carboxamide Compositions and Methods for Cellular Proliferation." This application includes compounds such as N-(3-substituted thiazaheterocyclylidene)-1H-pyrrolo[2,3-b]pyridine-3-carboxamides, N-(3-substituted thiazaheterocyclylidene)-1H-pyrrolo[2,3-b]pyridine-4-carboxamides, and N-(3-substituted thiazaheterocyclylidene)-1H-pyrrolo[3,2-b]pyridine-1-carboxamides. These compounds are designed to activate Yap and inhibit Lats kinases, making them useful for treating hearing loss. Another application is titled "Pyrrolo[2,3-b]pyridine-3-Carboxamide Compositions and Methods for Ameliorating Hearing Loss," which includes N-(3-Substituted thiazol-2(3H)-ylidene)-1H-pyrrolo[2,3-b]pyridine-3-carboxamides and N-(3-substituted oxazol-2(3H)-ylidene)-1H-pyrrolo[2,3-b]pyridine-3-carboxamides.
Conclusion: Nathaniel Kastan is a promising inventor whose research has the potential to impact the fields of cellular proliferation and hearing loss treatment. His innovative patent applications reflect his commitment to advancing biomedical science.